Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide-naïve chronic hepatitis B patients in Korea: data from the clinical practice setting in a single-center cohort

BACKGROUND/AIMS: This study assessed the antiviral efficacy and safety of tenofovir disoproxil fumarate (TDF) for up to 12 months in Korean treatment-naïve chronic hepatitis B (CHB) patients. METHODS: A total of 411 treatment-naïve CHB patients who had been treated with TDF for at least 3 months (me...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahn, Sung Soo, Chon, Young Eun, Kim, Beom Kyung, Kim, Seung Up, Kim, Do Young, Ahn, Sang Hoon, Han, Kwang-Hyub, Park, Jun Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197174/
https://www.ncbi.nlm.nih.gov/pubmed/25320729
http://dx.doi.org/10.3350/cmh.2014.20.3.261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197174/
https://www.ncbi.nlm.nih.gov/pubmed/25320729
http://dx.doi.org/10.3350/cmh.2014.20.3.261

Ejemplares similares